Pharmaceutical - GlaxoSmithKline, Legal

Filter

Current filters:

GlaxoSmithKlineLegal

Popular Filters

1 to 25 of 33 results

GSK spies indicted in China for illegally obtaining information

GSK spies indicted in China for illegally obtaining information

15-07-2014

A couple allegedly working for UK pharma major GlaxoSmithKline in China have been indicted in Shanghai…

ChinaGlaxoSmithKlineGSKLegalPharmaceuticalXinhua News AgencyXinhua News Agency

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

05-06-2014

UK pharma giant GlaxoSmithKline has agreed to a $105 million settlement with 44 US states and the District…

AdvairFinancialGlaxoSmithKlineLegalMarkets & MarketingNeurologicalPaxilPharmaceuticalRespiratory and PulmonaryUSAWellbutrin

GlaxoSmithKline now faces UK SFO inquiry into commercial practices

GlaxoSmithKline now faces UK SFO inquiry into commercial practices

28-05-2014

UK pharma giant GlaxoSmithKline, already subject to allegations of bribery of doctors and hospitals in…

GlaxoSmithKlineLegalMarkets & MarketingPharmaceuticalUK

GlaxoSmithKline now accused of tax evasion in China

19-05-2014

The Legal Daily, the official newspaper of the Chinese Ministry of Justice, on Friday accused UK pharma…

ChinaFinancialGlaxoSmithKlineLegalPharmaceutical

Police close investigation on GlaxoSmithKline China's bribery case

Police close investigation on GlaxoSmithKline China's bribery case

14-05-2014

Chinese police have finished the investigation on the suspected bribery case of the local subsidiary…

ChinaGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

GSK faces bribery allegations in Poland

GSK faces bribery allegations in Poland

14-04-2014

UK pharma major GlaxoSmithKline is facing allegations of bribing doctors in Poland, according to the…

BBCGlaxoSmithKlineGSK regional managerLegalMajorMedicinePharmaceuticalPolandPulmonologyRespiratory and PulmonarySeretideUK

Report: Health care companies lead the way in corporate compliance

27-12-2013

Health care companies are leading the way in terms of public trust and transparency, according to The…

AstraZenecaGlaxoSmithKlineLegalManagementPharmaceuticalReckitt BenckiserUK

US Appeals Court reverses 2012 decision on Lovaza, clearing way for generics

13-09-2013

Reversing a district court decision last year (The Pharma Letter May 30, 2012), the US Court of Appeals…

AmarinCardio-vascularGenericsGlaxoSmithKlineLegalLovazaNorth AmericaPar PharmaceuticalsPatentsPharmaceuticalTeva Pharmaceutical IndustriesVascepa

AHF sues GSK for failing to provide discounts on HIV/AIDS drugs

11-09-2013

The USA-based AIDS Healthcare Foundation (AHF) said yesterday (September 10) that it has filed a law…

Anti-viralsGlaxoSmithKlineLegalNorth AmericaPharmaceuticalPricing

GlaxoSmithKline could be considering quitting China, says BBC editor

06-09-2013

For most multinational companies, it is a no-brainer that they have to be big in China, if their global…

Asia-PacificGlaxoSmithKlineLegalManagementMarkets & MarketingPharmaceutical

Chinese police reveal more on GSK China's suspected violations

03-09-2013

The Chinese police have recently revealed more details about suspected economic violations by UK pharma…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

Another blow for Pharma, as India revokes Tykerb patent

02-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…

Asia-PacificGlaxoSmithKlineLegalOncologyPatentsPharmaceuticalTykerb

More details emerge of GSK China bribery allegations

26-07-2013

The extent of the alleged bribery and tax-related violations by UK pharma major GlaxoSmithKline (LSE:…

Asia-PacificGlaxoSmithKlineLegalPharmaceutical

Investigation on-going as claims GSK staff may have broken Chinese law

22-07-2013

Sales staff at UK pharma major GlaxoSmithKline (LSE: GSK) in China may have broken Chinese law, the company…

Asia-PacificGlaxoSmithKlineLegalPharmaceutical

China says GSK probe part of business climate clean-up

17-07-2013

China's probe into UK pharma major GlaxoSmithKline (LSE: GSK) was part of the country's efforts to improve…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

US Court denies re-hearing of Arzerra patent case

16-07-2013

Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

China probe into GlaxoSmithKline bribery allegations escalates

16-07-2013

Investigations in China relating to alleged bribery and tax-related crimes by UK pharma giant GlaxoSmithKline…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

UK's OFT accuses GlaxoSmithKline of "market abuse"

19-04-2013

The UK's Office of Fair Trading (OFT) today (April 19) issued a Statement of Objections to certain pharmaceutical…

AlpharmaEuropeGenericsGlaxoSmithKlineLegalMarkets & MarketingNeurologicalNorton HealthcarePaxilPharmaceuticalPricingSeroxat

News briefs on Sanofi, Novo Nordisk and GlaxoSmithKline/Amicus

20-12-2012

Two US subsidiaries of French drug major Sanofi (Euronext: SAN) have agreed to pay $109 million to resolve…

Amicus TherapeuticsAmigalDiabetesFIAspFinancialGlaxoSmithKlineHyalganIDegLiraLegalNorth AmericaNovo NordiskPharmaceuticalRare diseasesResearchSanofi

GSK settlement still not enough to deter Pharma, says Public Citizen

03-07-2012

This week's announcement of the largest health fraud settlement ever reached between a pharmaceutical…

FinancialGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

GlaxoSmithKline to plead guilty and pay record $3 billion to resolve US fraud allegations

03-07-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has agreed to plead guilty and to pay $3 billion - the largest…

FinancialGlaxoSmithKlineLegalMarkets & MarketingNorth AmericaPharmaceutical

1 to 25 of 33 results

Back to top